Navigation Links
Aon Benfield Forecasts Potential Impact on the Insurance Industry Resulting From the Alleged Madoff Scandal
Date:1/14/2009

LONDON and CHICAGO, Jan. 14 /PRNewswire-FirstCall/ -- Aon Benfield, the world's premier reinsurance intermediary and capital advisor, released today a preliminary forecast of direct insured losses resulting from the alleged Bernard Madoff Ponzi scheme.

(Logo: http://www.newscom.com/cgi-bin/prnh/20041215/CGW049LOGO)

"While the maximum potential exposed insurance limits are estimated to be over $6 billion, the range of direct insured losses will be a far smaller number, most likely somewhere between $760 million and $3.8 billion, with a best estimate of $1.8 billion," said Stephen Mildenhall, head of Aon Benfield's Actuarial and Enterprise Risk Management practice. "These figures represent material costs, but are not likely to have a significant impact on the insurance industry," he continued.

The high end of the likely range of insured losses represents less than 20 loss ratio points on global Directors & Officers, Errors & Omissions, and Fidelity premium. Since most insurance claims will be concentrated in the financial institution sector, the loss ratio within this specific segment may be significant. Based on estimated financial institution insurance premiums, the loss ratio impact could range from 40 to 180 loss ratio points in this specific segment. Given the claims-made nature of most professional liability coverage, losses would likely be spread over policy years 2007 and 2008 (or report years 2008 and 2009).

"When the effect of this scandal is combined with the impact of the ongoing credit crisis, many insurers will see profitability deteriorate even further in their financial institutions book of business," concluded Mr. Mildenhall. "Optimists may point to a potentially positive outcome -- a more rapid hardening of rates in the professional liability market."

Aon Benfield will continue to update this preliminary analysis and revise results as new information becomes available. A copy of the preliminary report released today is available upon request.

About Aon Benfield

Aon Benfield is the world's premier reinsurance intermediary and capital advisor, providing clients with integrated capital solutions and services. The company offers clients access to every traditional and alternative market in the world, through an international network of offices spanning over 50 countries and more than 4,000 professionals. Its worldwide client base is able to access the broadest portfolio of integrated capital solutions and services, world-class talent, unparalleled global reach and local expertise to best meet their business objectives. Aon Benfield is the industry leader in treaty, facultative and capital markets transactions.

    For further information please contact:

    David Bogg                               Kathleen Hipp
    London                                   Minneapolis
    t: +44 (0)20 7522 4016                   t: +1 952 886 8161
    e: david.bogg@aonbenfield.com            e: kathleen.hipp@aonbenfield.com


'/>"/>
SOURCE Aon Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. NOAA Hourly Air Quality Ozone Forecasts Now Available Coast to Coast
2. UCAR weather forecasts aim to reduce African meningitis epidemics
3. The Noblis Center for Health Innovation Forecasts 2009 Trends In Provider Health Care Delivery
4. DNA vaccine against multiple sclerosis appears safe, potentially beneficial
5. UCLA study identifies designer estrogen as potential MS drug
6. Office-Based Medical Treatment and Internet Resources Are Potential Solution to Rising Painkiller Misuse Among Teens, Young Adults
7. Common abdominal pain may be due to a potentially treatable newly recognized inflammatory reaction
8. Potential new approach to treat cognitive impairments in schizophrenia
9. Nosespray vaccine using aloe vera has exciting potential, researcher says
10. Network approach identifies potential breast cancer susceptibility gene
11. Liver fibrosis will be treated by a potential target
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... ... 2016 , ... Global Lyme Alliance (GLA), a leading nonprofit ... has named Scott Santarella as its new CEO. , Santarella is former ... San Francisco, where he successfully helped to grow the organization from a regional ...
(Date:5/24/2016)... ... May 24, 2016 , ... Researchers ... of protocols designed to reduce bleeding complications from percutaneous coronary intervention (PCI). The ... Interventions (SCAI) in Orlando, FL, document a 40% reduction in risk-adjusted bleeding event ...
(Date:5/24/2016)... ... May 24, 2016 , ... Design Concepts ... ‘El Centro del Quinto Sol Wheel Park’ in Pueblo, Colorado. This park was ... offer something special for this often overlooked neighborhood. Located at 609 E. 6th ...
(Date:5/24/2016)... ... May 24, 2016 , ... Celebration is in ... kicked off its 5th Annual Photo Contest. The label contest is underway, and ... year's prizes include a GoPro Hero4, a 40-inch high-definition flat-screen television, an Apple ...
(Date:5/23/2016)... (PRWEB) , ... May 23, 2016 , ... On the ... took the time to summarize the weight loss process: , New patients have a ... Composition Analysis (BCA) to get accurately evaluated. , Body Composition Analysis, There are 15 ...
Breaking Medicine News(10 mins):
(Date:5/23/2016)... 23, 2016 Experts from various ... Medicine and the role of technology in innovative ... The First International Conference of VPS-Penn Medicine opened in ... and presence of Sheikh Nahyan bin Mubarak Al Nahyan, Minister ... Medicine, which helps provide personalized medicine and tailor-made healthcare in ...
(Date:5/23/2016)... , May 23, 2016 The ... USD 5.0 billion by 2022, according to a new ... of medical waste coupled with the lack of centralized ... expected to drive the demand for reprocessed medical devices ... as compared to that of the original device is ...
(Date:5/22/2016)... DUBLIN , May 23, 2016 ... to develop its anti-fibrotic and anti-inflammatory compound DS102 ... well as in non-alcoholic steatohepatitis (NASH) patients. ... is significantly sequestered in lung tissue and has ... tissue after oral administration. The Company will publish ...
Breaking Medicine Technology: